Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene

Deeksha S. Bali, Jennifer L. Goldstein, Keri Fredrickson, Catherine Rehder, Anne Boney, Stephanie Austin, David A. Weinstein, Richard E Lutz, Avihu Boneh, Priya S. Kishnani

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Liver phosphorylase b kinase (PhK) deficiency (glycogen storage disease type IX), one of the most common causes of glycogen storage disease, is caused by mutations in the PHKA2, PHKB, and PHKG2 genes. Presenting symptoms include hepatomegaly, ketotic hypoglycemia, and growth delay. Clinical severity varies widely. Autosomal recessive mutations in the PHKG2 gene, which cause about 10-15% of cases, have been associated with severe symptoms including increased risk of liver cirrhosis in childhood. We have summarized the molecular, biochemical, and clinical findings in five patients, age 5-16. years, diagnosed with liver PhK deficiency caused by PHKG2 gene mutations. We have identified five novel and two previously reported mutations in the PHKG2 gene in these five patients. Clinical severity was variable among these patients. Histopathological studies were performed for four of the patients on liver biopsy samples, all of which showed signs of fibrosis but not cirrhosis. One of the patients (aged 9. years) developed a liver adenoma which later resolved. All patients are currently doing well. Their clinical symptoms have improved with age and treatment. These cases add to the current knowledge of clinical variability in patients with PHKG2 mutations. Long term studies, involving follow-up of these patients into adulthood, are needed.

Original languageEnglish (US)
Pages (from-to)309-313
Number of pages5
JournalMolecular Genetics and Metabolism
Volume111
Issue number3
DOIs
StatePublished - Mar 1 2014

Fingerprint

Phosphorylase Kinase
Liver
Genes
Mutation
Glycogen
Glycogen Storage Disease
Biopsy
Fibrosis
Hepatomegaly
Glycogen Storage Disease Type Ix
Hypoglycemia
Liver Cirrhosis
Adenoma

Keywords

  • Glycogen storage disease type IX
  • Hypoglycemia
  • Liver adenoma
  • PHKG2 gene
  • Phosphorylase b kinase deficiency

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. / Bali, Deeksha S.; Goldstein, Jennifer L.; Fredrickson, Keri; Rehder, Catherine; Boney, Anne; Austin, Stephanie; Weinstein, David A.; Lutz, Richard E; Boneh, Avihu; Kishnani, Priya S.

In: Molecular Genetics and Metabolism, Vol. 111, No. 3, 01.03.2014, p. 309-313.

Research output: Contribution to journalArticle

Bali, DS, Goldstein, JL, Fredrickson, K, Rehder, C, Boney, A, Austin, S, Weinstein, DA, Lutz, RE, Boneh, A & Kishnani, PS 2014, 'Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene', Molecular Genetics and Metabolism, vol. 111, no. 3, pp. 309-313. https://doi.org/10.1016/j.ymgme.2013.12.008
Bali, Deeksha S. ; Goldstein, Jennifer L. ; Fredrickson, Keri ; Rehder, Catherine ; Boney, Anne ; Austin, Stephanie ; Weinstein, David A. ; Lutz, Richard E ; Boneh, Avihu ; Kishnani, Priya S. / Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene. In: Molecular Genetics and Metabolism. 2014 ; Vol. 111, No. 3. pp. 309-313.
@article{ac3c63011a184a08989d507703fdb9a3,
title = "Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene",
abstract = "Liver phosphorylase b kinase (PhK) deficiency (glycogen storage disease type IX), one of the most common causes of glycogen storage disease, is caused by mutations in the PHKA2, PHKB, and PHKG2 genes. Presenting symptoms include hepatomegaly, ketotic hypoglycemia, and growth delay. Clinical severity varies widely. Autosomal recessive mutations in the PHKG2 gene, which cause about 10-15{\%} of cases, have been associated with severe symptoms including increased risk of liver cirrhosis in childhood. We have summarized the molecular, biochemical, and clinical findings in five patients, age 5-16. years, diagnosed with liver PhK deficiency caused by PHKG2 gene mutations. We have identified five novel and two previously reported mutations in the PHKG2 gene in these five patients. Clinical severity was variable among these patients. Histopathological studies were performed for four of the patients on liver biopsy samples, all of which showed signs of fibrosis but not cirrhosis. One of the patients (aged 9. years) developed a liver adenoma which later resolved. All patients are currently doing well. Their clinical symptoms have improved with age and treatment. These cases add to the current knowledge of clinical variability in patients with PHKG2 mutations. Long term studies, involving follow-up of these patients into adulthood, are needed.",
keywords = "Glycogen storage disease type IX, Hypoglycemia, Liver adenoma, PHKG2 gene, Phosphorylase b kinase deficiency",
author = "Bali, {Deeksha S.} and Goldstein, {Jennifer L.} and Keri Fredrickson and Catherine Rehder and Anne Boney and Stephanie Austin and Weinstein, {David A.} and Lutz, {Richard E} and Avihu Boneh and Kishnani, {Priya S.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1016/j.ymgme.2013.12.008",
language = "English (US)",
volume = "111",
pages = "309--313",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene

AU - Bali, Deeksha S.

AU - Goldstein, Jennifer L.

AU - Fredrickson, Keri

AU - Rehder, Catherine

AU - Boney, Anne

AU - Austin, Stephanie

AU - Weinstein, David A.

AU - Lutz, Richard E

AU - Boneh, Avihu

AU - Kishnani, Priya S.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Liver phosphorylase b kinase (PhK) deficiency (glycogen storage disease type IX), one of the most common causes of glycogen storage disease, is caused by mutations in the PHKA2, PHKB, and PHKG2 genes. Presenting symptoms include hepatomegaly, ketotic hypoglycemia, and growth delay. Clinical severity varies widely. Autosomal recessive mutations in the PHKG2 gene, which cause about 10-15% of cases, have been associated with severe symptoms including increased risk of liver cirrhosis in childhood. We have summarized the molecular, biochemical, and clinical findings in five patients, age 5-16. years, diagnosed with liver PhK deficiency caused by PHKG2 gene mutations. We have identified five novel and two previously reported mutations in the PHKG2 gene in these five patients. Clinical severity was variable among these patients. Histopathological studies were performed for four of the patients on liver biopsy samples, all of which showed signs of fibrosis but not cirrhosis. One of the patients (aged 9. years) developed a liver adenoma which later resolved. All patients are currently doing well. Their clinical symptoms have improved with age and treatment. These cases add to the current knowledge of clinical variability in patients with PHKG2 mutations. Long term studies, involving follow-up of these patients into adulthood, are needed.

AB - Liver phosphorylase b kinase (PhK) deficiency (glycogen storage disease type IX), one of the most common causes of glycogen storage disease, is caused by mutations in the PHKA2, PHKB, and PHKG2 genes. Presenting symptoms include hepatomegaly, ketotic hypoglycemia, and growth delay. Clinical severity varies widely. Autosomal recessive mutations in the PHKG2 gene, which cause about 10-15% of cases, have been associated with severe symptoms including increased risk of liver cirrhosis in childhood. We have summarized the molecular, biochemical, and clinical findings in five patients, age 5-16. years, diagnosed with liver PhK deficiency caused by PHKG2 gene mutations. We have identified five novel and two previously reported mutations in the PHKG2 gene in these five patients. Clinical severity was variable among these patients. Histopathological studies were performed for four of the patients on liver biopsy samples, all of which showed signs of fibrosis but not cirrhosis. One of the patients (aged 9. years) developed a liver adenoma which later resolved. All patients are currently doing well. Their clinical symptoms have improved with age and treatment. These cases add to the current knowledge of clinical variability in patients with PHKG2 mutations. Long term studies, involving follow-up of these patients into adulthood, are needed.

KW - Glycogen storage disease type IX

KW - Hypoglycemia

KW - Liver adenoma

KW - PHKG2 gene

KW - Phosphorylase b kinase deficiency

UR - http://www.scopus.com/inward/record.url?scp=84894449637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894449637&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2013.12.008

DO - 10.1016/j.ymgme.2013.12.008

M3 - Article

C2 - 24389071

AN - SCOPUS:84894449637

VL - 111

SP - 309

EP - 313

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 3

ER -